DelveInsight’s Chronic Obstructive Pulmonary Disease (COPD) Market report puts forward a detailed perspective on epidemiology, current treatment practices, emerging drugs, COPD market share of the individual therapies, current and forecasted Chronic Obstructive Pulmonary Disease market size for the study period 2018 to 2030 spanning across 7MM (the USA, EU5 (the UK, Italy, Spain, France, and Germany), and Japan).
Key highlights from the Chronic Obstructive Pulmonary Disease Market report:
Download Sample report to understand which drug is going to nab the maximum market share @ https://www.delveinsight.com/sample-request/chronic-obstructive-pulmonary-disease-copd-market
Chronic Obstructive Pulmonary Disease: Overview
Chronic Obstructive Pulmonary Disease is a major health problem characterized by progressive airflow limitation and tissue destruction. It is majorly of two types: Chronic Bronchitis and Emphysema. Chronic bronchitis results in inflammation and irritation of the airways making the lining of the airways thick, whereas Emphysema damages the walls of the alveolar sacs reducing the amount of gas exchange in the lungs.
With the advances in every field such as medical technology, awareness of the disease, huge strides of improvements have been taken in properly mapping the COPD epidemiology, clinical features and presentation, associated comorbidities, and treatment.
Chronic Obstructive Pulmonary Disease Epidemiology
Chronic Obstructive Pulmonary Disease is currently the third most common cause of global morbidity and mortality. As per COPD epidemiological analysis, COPD is primarily present in smokers, especially in the age group >40 years. The COPD prevalence increases with the age, however, the prevalence is most likely underestimated owing to the underdiagnosis of COPD.
Chronic Obstructive Pulmonary Disease Market Insights Report offers historical as well as forecasted epidemiological analysis during the study period 2018-30 in the 7MM segmented into:
Visit for deep insights into Chronic Obstructive Pulmonary Disease patient pool @ https://www.delveinsight.com/sample-request/chronic-obstructive-pulmonary-disease-copd-market
Chronic Obstructive Pulmonary Disease Therapy Market
The primary goal of COPD treatment remains alleviating symptoms and addressing exacerbations, reducing mortality rate, and altering the underlying nature of the disease (otherwise known as ‘disease modification’).
Currently, there are 9 approved drug categories for COPD maintenance medication. However, the majority of these available treatment options are largely iterations of bronchodilators, which open airways and but no pharmacological treatment has the potential to prevent the progression of lung destruction. The only way to stop the disease from getting worse is to stop smoking.
Check out for more @ Chronic Obstructive Pulmonary Disease Market Forecast
COPD Available Therapies and Treatment Options
Visit to know more @ https://www.delveinsight.com/sample-request/chronic-obstructive-pulmonary-disease-copd-market
Key Pharma Companies in the Chronic Obstructive Pulmonary Disease Market
Chronic Obstructive Pulmonary Disease Market Drivers and Barriers
All of the available drugs and therapies in the COPD therapy market are symptomatic in nature. In the last decade, only one drug has entered the COPD market. However, a better understanding of the disease and its pathophysiology has surged the development of therapies in the COPD market. Besides, a growing prevalence and an aging population are also pushing the market growth.
Novel investigational products in development targeting immune mediators are expected to show promising results on this front. The updated diagnosis paradigm, validation, and approval of patient-reported outcome questionnaires for clinical trials, and drug development tools, such as a prognostic biomarker for patient selection have further helped in stepping up the therapeutic approaches that are efficient, safe, and effective.
Lastly, the increasing number of government initiatives along with nongovernment organizations have successfully managed to bring a lot of awareness around pollution and smoking that are major causes of COPD, thereby, impacting lifestyle in a positive manner and increase adoption of the drugs for treatment, ultimately, leading to vertical growth.
Table of Contents
1
Key Insights
2
Chronic Obstructive Pulmonary Disease Market Report Introduction
3
Chronic Obstructive Pulmonary Disease Market Overview at a Glance
4
Executive Summary of Chronic Obstructive Pulmonary Disease
5
Disease Background and Overview
6
Algorithm for Diagnosis of Chronic Obstructive Pulmonary Disease
7
Patient Journey
8
Chronic Obstructive Pulmonary Disease Epidemiology and Patient Population
9
Treatment Algorithm, Current Treatment, and Medical Practices
10
11
Country Wise Epidemiology of COPD
Chronic Obstructive Pulmonary Disease Treatment
12
Unmet Needs
13
Key Endpoints of Chronic Obstructive Pulmonary Disease Treatment
14
Chronic Obstructive Pulmonary Disease Emerging Therapies
15
Chronic Obstructive Pulmonary Disease: 7 Major Market Analysis
16
Chronic Obstructive Pulmonary Disease Market Unmet Needs
17
Case Reports
18
COPD Market Drivers
19
Chronic Obstructive Pulmonary Disease Market Barriers
20
SWOT Analysis
21
KOL Reviews
Appendix
22
DelveInsight Capabilities
23
Disclaimer
24
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Ankit NigamEmail: Send EmailPhone: +19193216187Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/report-store/chronic-obstructive-pulmonary-disease-copd-market